Description

The sodium iodide symporter (NIS) is a membrane protein that drives uptake of iodine into cells. Mammals express NIS endogenously in the thyroid, salivary glands, gastric mucosa, and mammary glands. And other cell types and viruses can be engineered to express recombinant NIS.

NIS concentrates radioactive iodine as well as several other radiotracers, so it can be used to noninvasively track cells in vivo through nuclear imaging. NIS imaging has several key advantages: it produces high-resolution 3D images that are fully quantitative, it is translational from small to large animals as well as humans, and it can be used for longitudinal imaging studies as the species-specific NIS proteins are non-immunogenic. 

How to use NIS for imaging

Reagents: NIS concentrates a number of different radiotracers, several of which are clinically approved.

Equipment: SPECT or PET machines can be used to detect radiotracer signal and biodistribution of NIS-expressing cells or virus. Combining SPECT or PET with computed tomography (CT) or magnetic resonance (MR) imaging gives the most informative results, as images can be co-registered to give anatomical localization of the radiotracer signal.

Additional considerations: Depending on the location of the target organs for imaging, administration of undiluted barium sulfate prior to imaging can be used to block endogenous NIS signal in the stomach.

Workflow:

When to use NIS

NIS is well suited for longitudinal, noninvasive imaging studies in regenerative medicine, gene therapy, oncology, and oncolytic virotherapy, where it can be used to track the biodistribution of cell/virus therapies or the destruction of tumors. NIS can be used for small or large animal imaging and is translatable to the clinic. The heart, lungs, liver, kidneys, orthopedics (joints and bone), and immune cells are all suitable organs for NIS imaging.